Literature DB >> 19210647

Use of inhaled fluticasone propionate to control respiratory manifestations of relapsing polychondritis.

Takahiro Tsuburai1, Motoyoshi Suzuki, Naomi Tsurikisawa, Emiko Ono, Chiyako Oshikata, Masami Taniguchi, Kazuo Akiyama.   

Abstract

Effective management of respiratory tract involvement is very important in improving the prognosis of relapsing polychondritis (RPC). This case report describes a 19-year-old patient with RPC, who required frequent hospitalization due to recurrent exacerbations of airway obstruction. Use of high-dose fluticasone propionate effectively reduced the amount of oral corticosteroid necessary to control inflammation of the airway mucosa and dramatically decreased the patient's obstructive airway impairment. This report is the first illustrating the effectiveness and safety of inhaled corticosteroids in the control of the respiratory manifestations of RPC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19210647     DOI: 10.1111/j.1440-1843.2008.01455.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  3 in total

Review 1.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

2.  Relapsing polychondritis after treatment with PD-1 blockade.

Authors:  Tatsuya Ogimoto; Hironori Yoshida; Masanobu Mizuta; Toyohiro Hirai
Journal:  Invest New Drugs       Date:  2021-09-25       Impact factor: 3.651

Review 3.  Small cell lung cancer with relapsing polychondritis: A report of one case and the review of literature.

Authors:  Yuan Liu; Ning Wang; Jian Xu; Ying Bi; Xue Han; Meng Dai; Chunfang Liu
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.